What a fantastic time to be in the world of scientific discovery. I have been at the bench, in the halls of academia (as a student and medical writer), worked in industry, employed as a medical education executive, and most recently, I work as a datapreneur. What is that? I like to describe datapreneur as a journalist taking cues only from data.
Discovery in the sciences is dynamic. Regardless of your pedigree or educational attainment, if you aren't in lockstep with advances in your chosen discipline, you are obsolete. There is texture in experience. And insights to gain from tireless scientists hoping to advance if not a cure perhaps a better quality of life during advanced and chronic cancers.
Discovery in the sciences is dynamic. Regardless of your pedigree or educational attainment, if you aren't in lockstep with advances in your chosen discipline, you are obsolete. There is texture in experience. And insights to gain from tireless scientists hoping to advance if not a cure perhaps a better quality of life during advanced and chronic cancers.
I need time to review my recent experiences at several recent conferences. The topics are particularly appropriate to this forum so follow along. Not everyone can jet off to conferences listening to leading minds debate checkpoint inhibition, cancer vaccines, or perhaps most importantly--how to apply statistical models to a new paradigm of data generation. My schedule visible on the right (or who knows where in the mobile app--I know--I am working on it) is one day of a 5-day schedule of block presentations around specific topics in immunology. How often are you reading late-breaking abstracts from a recent conference wishing you knew more about the methodological approach selected or consideration of patient selection? Immunology 2017 was easily one of the most data and science heavy conferences I have attended--the Q&A sessions and live abstract presentations were fascinating. Seasoned scientists would applaud and ask for clarifications on statistical modeling, clinical endpoints, and broad or narrow applicability of research findings. If you want to stay in the "know" sign up for the mailing list or follow along on social media. We have a lot of "incredible" to discover... |